These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 12090474)

  • 1. Non-glycosylated tandem repeats of MUC1 facilitate attachment of breast tumor cells to normal human lung tissue and immobilized extracellular matrix proteins (ECM) in vitro: potential role in metastasis.
    Ciborowski P; Finn OJ
    Clin Exp Metastasis; 2002; 19(4):339-45. PubMed ID: 12090474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1.
    Ryuko K; Schol DJ; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Karuntu-Wanamarta YA; Verstraeten RA; Miyazaki K; Kenemans P; Hilgers J
    Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear magnetic resonance-based dissection of a glycosyltransferase specificity for the mucin MUC1 tandem repeat.
    Brokx RD; Revers L; Zhang Q; Yang S; Mal TK; Ikura M; Gariépy J
    Biochemistry; 2003 Dec; 42(47):13817-25. PubMed ID: 14636048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion.
    Schroeder JA; Adriance MC; Thompson MC; Camenisch TD; Gendler SJ
    Oncogene; 2003 Mar; 22(9):1324-32. PubMed ID: 12618757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing the conformational and dynamical effects of O-glycosylation within the immunodominant region of a MUC1 peptide tumor antigen.
    Schuman J; Campbell AP; Koganty RR; Longenecker BM
    J Pept Res; 2003 Mar; 61(3):91-108. PubMed ID: 12558945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumor cell extracts.
    Nishimori I; Perini F; Mountjoy KP; Sanderson SD; Johnson N; Cerny RL; Gross ML; Fontenot JD; Hollingsworth MA
    Cancer Res; 1994 Jul; 54(14):3738-44. PubMed ID: 8033093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
    Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
    J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
    Spencer DI; Missailidis S; Denton G; Murray A; Brady K; Matteis CI; Searle MS; Tendler SJ; Price MR
    Biospectroscopy; 1999; 5(2):79-91. PubMed ID: 10217327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of acceptor substrate primary amino acid sequence on the activity of human UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferase. Studies with the MUC1 tandem repeat.
    Nishimori I; Johnson NR; Sanderson SD; Perini F; Mountjoy K; Cerny RL; Gross ML; Hollingsworth MA
    J Biol Chem; 1994 Jun; 269(23):16123-30. PubMed ID: 8206912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients.
    Snijdewint FG; von Mensdorff-Pouilly S; Karuntu-Wanamarta AH; Verstraeten AA; Livingston PO; Hilgers J; Kenemans P
    Int J Cancer; 2001 Jul; 93(1):97-106. PubMed ID: 11391628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential glycosylation of MUC1 in tumors and transfected epithelial and lymphoblastoid cell lines.
    Poland PA; Kinlough CL; Rokaw MD; Magarian-Blander J; Finn OJ; Hughey RP
    Glycoconj J; 1997 Jan; 14(1):89-96. PubMed ID: 9076518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human tumor antigen MUC1 expressed in insect cells: structure and immunogenicity.
    Soares M; Hanisch FG; Finn OJ; Ciborowski P
    Protein Expr Purif; 2001 Jun; 22(1):92-100. PubMed ID: 11388805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC1 isoform specific monoclonal antibody 6E6/2 detects preferential expression of the novel MUC1/Y protein in breast and ovarian cancer.
    Hartman M; Baruch A; Ron I; Aderet Y; Yoeli M; Sagi-Assif O; Greenstein S; Stadler Y; Weiss M; Harness E; Yaakubovits M; Keydar I; Smorodinsky NI; Wreschner DH
    Int J Cancer; 1999 Jul; 82(2):256-67. PubMed ID: 10389761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MUC1 glycoforms in breast cancer--cell line T47D as a model for carcinoma-associated alterations of 0-glycosylation.
    Hanisch FG; Stadie TR; Deutzmann F; Peter-Katalinic J
    Eur J Biochem; 1996 Feb; 236(1):318-27. PubMed ID: 8617281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line.
    Kohlgraf KG; Gawron AJ; Higashi M; Meza JL; Burdick MD; Kitajima S; Kelly DL; Caffrey TC; Hollingsworth MA
    Cancer Res; 2003 Aug; 63(16):5011-20. PubMed ID: 12941828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and molecular cloning of a novel MUC1 protein, devoid of tandem repeats, expressed in human breast cancer tissue.
    Zrihan-Licht S; Vos HL; Baruch A; Elroy-Stein O; Sagiv D; Keydar I; Hilkens J; Wreschner DH
    Eur J Biochem; 1994 Sep; 224(2):787-95. PubMed ID: 7925397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant MUC1 probe authentically reflects cell-specific O-glycosylation profiles of endogenous breast cancer mucin. High density and prevalent core 2-based glycosylation.
    Müller S; Hanisch FG
    J Biol Chem; 2002 Jul; 277(29):26103-12. PubMed ID: 12000758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of polymorphism in MUC1 tandem repeats in cancer cells is related to breast cancer progression in Japanese women.
    Kawaguchi T; Takazawa H; Imai S; Morimoto J; Watanabe T
    Breast Cancer Res Treat; 2005 Aug; 92(3):223-30. PubMed ID: 16155793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and functional characterization of a human GalNAc [alpha]2,6-sialyltransferase with altered expression in breast cancer.
    Sotiropoulou G; Kono M; Anisowicz A; Stenman G; Tsuji S; Sager R
    Mol Med; 2002 Jan; 8(1):42-55. PubMed ID: 11984005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Core-glycosylated mucin-like repeats from MUC1 are an apical targeting signal.
    Kinlough CL; Poland PA; Gendler SJ; Mattila PE; Mo D; Weisz OA; Hughey RP
    J Biol Chem; 2011 Nov; 286(45):39072-81. PubMed ID: 21937430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.